The anonymous community for clinical research professionals. Verified with a work email, posted under a pseudonym.
Editorial · Job moves · 44d · Open Label Desk [Editorial]
Regulatory affairs has its own certification, and unlike most, it is aimed squarely at experienced professionals. What the RAC requires, what it costs, and who it is for.
Read the piece →
Editorial · Job moves · 44d · Open Label Desk [Editorial]
The PMP is a general project management credential, not a clinical one. For clinical trial managers weighing it, here is what it signals, what it costs, and the catch in its pay claims.
Read the piece →
Editorial · Job moves · 44d · Open Label Desk [Editorial]
The industry is shifting toward functional service provider staffing, where you work badged inside a sponsor. It offers stability and a narrower job. Know the trade before you take it.
Read the piece →
Editorial · Job moves · 44d · Open Label Desk [Editorial]
Two credentialing bodies dominate clinical research, and newcomers waste real money guessing between them. What each certification is, how they differ, and how to choose.
Read the piece →
Editorial · Job moves · 45d · Open Label Desk [Editorial]
An FDA finding does not just cost remediation. It can make a site un-selectable and an investigator un-hirable. How inspection history follows a career, and how to check it.
Read the piece →
Editorial · Job moves · 45d · Open Label Desk [Editorial]
The registry names the sponsor on every trial. Rank the big pharma names by active recruitment and you get a directional map of where the sponsor-side demand is.
Read the piece →
Editorial · Job moves · 45d · Open Label Desk [Editorial]
The catch-22 everyone hits: CRA jobs want CRA experience. The real entry paths that work, and what each one pays while you build the years.
Read the piece →
Question · Job moves · 48d · Open Label Desk [Editorial]
The most debated move in the industry. The usual trade, as reported from both directions: calendar and benefits improve, metrics pressure drops, the title effectively resets, and the ladder slows. The trade daily covers the math; this thread is for the parts nobody warns you about. If you made the jump either way, what surprised you?
Poll · Job moves · 49d · Open Label Desk [Editorial]
Assume same function, same level, heavier delivery pressure. The direction everyone debates, reduced to one tap.
0 votes · vote to see results
Question · Job moves · 49d · Open Label Desk [Editorial]
A pattern reported to us more than once this year: final-round interview processes that end in silence rather than a rejection. In an industry this small it seems self-defeating; the same candidates will be on the other side of a feasibility call next year. Is this the market right now, or bad luck concentrated in a few companies?
Editorial · Job moves · 52d · Open Label Desk [Editorial]
The most common career question in clinical research, priced out beyond the base salary.
Read the piece →
Editorial · Job moves · 59d · Open Label Desk [Editorial]
The offer letter tells you the salary. These questions tell you what the job actually costs.
Read the piece →